CG Oncology, Inc. Common stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 6.58 M | $264.93 M | 11.36% | 8.63% |
| DECHENG CAPITAL LLC | 11/14/2025 | 6.37 M | $256.65 M | 0.00% | 8.36% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 5.51 M | $222.05 M | 190.32% | 7.23% |
| BLACKROCK, INC. | 11/12/2025 | 4.59 M | $184.74 M | 2.92% | 6.02% |
| FMR LLC | 11/13/2025 | 3.87 M | $155.71 M | 0.25% | 5.07% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 3.67 M | $147.84 M | 0.00% | 4.81% |
| BRAIDWELL LP | 11/14/2025 | 3.28 M | $132.25 M | 0.00% | 4.31% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 11/14/2025 | 2.22 M | $89.48 M | 0.00% | 2.91% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 2.14 M | $86.12 M | -1.21% | 2.80% |
| UBS GROUP AG | 11/13/2025 | 2.13 M | $85.65 M | -4.62% | 2.79% |
| STATE STREET CORP | 11/14/2025 | 2.05 M | $82.44 M | -5.50% | 2.69% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 2.01 M | $80.77 M | -18.41% | 2.63% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.73 M | $69.56 M | -8.04% | 2.27% |
| RTW INVESTMENTS, LP | 11/14/2025 | 1.70 M | $68.52 M | 0.00% | 2.23% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 1.60 M | $64.48 M | 6.73% | 2.10% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.59 M | $64.00 M | -21.10% | 2.08% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.52 M | $61.36 M | 3.26% | 2.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.47 M | $59.35 M | 10.31% | 1.93% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.47 M | $59.18 M | -1.18% | 1.93% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.37 M | $55.06 M | 15.14% | 1.79% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.32 M | $53.11 M | -2.64% | 1.73% |
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 1.13 M | $45.58 M | 0.00% | 1.48% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 1.10 M | $44.25 M | 0.00% | 1.44% |
| CANDRIAM S.C.A. | 11/06/2025 | 1.04 M | $41.81 M | 35.92% | 1.36% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 11/14/2025 | 1.00 M | $40.44 M | 0.00% | 1.32% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 780.30 K | $31.43 M | -8.91% | 1.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 748.35 K | $30.14 M | -56.91% | 0.98% |
| MANGROVE PARTNERS | 11/14/2025 | 671.69 K | $27.06 M | 21.00% | 0.88% |
| MORGAN STANLEY | 11/14/2025 | 642.41 K | $25.88 M | -65.61% | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 638.35 K | $25.71 M | 17.99% | 0.84% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 625.00 K | $25.18 M | 0.00% | 0.82% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 613.85 K | $24.73 M | 100.00% | 0.81% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 579.90 K | $23.36 M | -1.15% | 0.76% |
| WOODLINE PARTNERS LP | 11/14/2025 | 571.48 K | $23.02 M | -9.20% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 525.52 K | $21.17 M | 16.71% | 0.69% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 11/07/2025 | 503.53 K | $20.28 M | -1.69% | 0.66% |
| NORTHERN TRUST CORP | 11/14/2025 | 491.34 K | $19.79 M | 4.96% | 0.64% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 452.35 K | $18.22 M | 74.51% | 0.59% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 410.00 K | $16.51 M | 54.14% | 0.54% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 396.48 K | $15.97 M | 0.00% | 0.52% |
| CENTERBOOK PARTNERS LP | 11/07/2025 | 395.34 K | $15.92 M | 52.00% | 0.52% |
| ROSALIND ADVISORS, INC. | 11/13/2025 | 300.00 K | $12.08 M | 55.46% | 0.39% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 290.00 K | $11.68 M | 87.10% | 0.38% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 257.23 K | $10.36 M | -12.21% | 0.34% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 253.18 K | $10.20 M | -73.63% | 0.33% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 249.47 K | $10.05 M | 60.95% | 0.33% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 248.92 K | $10.03 M | -52.43% | 0.33% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 247.75 K | $9.98 M | -0.77% | 0.33% |
| CITADEL ADVISORS LLC | 11/14/2025 | 238.77 K | $9.62 M | 36.24% | 0.31% |
| JPMORGAN CHASE & CO | 11/26/2025 | 227.88 K | $9.18 M | 321.26% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CG Oncology, Inc. Common stock institutional Ownership - FAQ's
During the previous two years, 202 institutional investors and hedge funds held shares of CG Oncology, Inc. Common stock. The most heavily invested institutionals were:
VANGUARD GROUP INC: 6.58 M
Decheng Capital LLC: 6.37 M
WELLINGTON MANAGEMENT GROUP LLP: 5.51 M
BlackRock, Inc.: 4.59 M
FMR LLC: 3.87 M
TCG Crossover Management, LLC: 3.67 M
101.87% of CG Oncology, Inc. Common stock stock is owned by institutional investors.
Institutional investors have bought a total of 80.00 M shares in the last 24 months. This purchase volume represents approximately $3.19 B in transactions.